Beta-blockers in acute coronary syndrome patients: The concept of ‘gradient of benefit’

Beta-blockers in acute coronary syndrome patients: The concept of ‘gradient of benefit’

Bibliographic Details
Main Authors:	Fernando Montenegro Sá, João Morais
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Revista Portuguesa de Cardiologia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255121003486

Similar Items

Reply to letter “Beta-blockers in acute coronary syndrome patients: The concept of ‘gradient of benefit”’
by: Jesús Velásquez-Rodríguez, et al.
Published: (2021-10-01)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
by: Marvin Kummer, et al.
Published: (2020-05-01)

Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome
by: Alexandre de Matos Soeiro, et al.

Predictors of beta-blocker intolerance and mortality in patients after acute coronary syndrome.
by: Laercio Martins De Stefano, et al.
Published: (2013-01-01)

Effect of beta-blocker dose on mortality after acute coronary syndrome
by: Sergio Raposeiras-Roubin, et al.
Published: (2018-03-01)

Effect of beta-blocker dose on mortality after acute coronary syndrome
by: Sergio Raposeiras-Roubin, et al.
Published: (2018-03-01)

USE OF BETA BLOCKERS IN ACUTE CORONARY SYNDROME IN SERBIA IN THE PERIOD 2000 – 2005
by: Vesna V. Radovic
Published: (2008-10-01)

The dilemma of beta-blocker use after acute coronary syndrome: To support the dogma or to embrace the paradigm shift?
by: Daniel Ferreira
Published: (2018-11-01)

The dilemma of beta-blocker use after acute coronary syndrome: To support the dogma or to embrace the paradigm shift?
by: Daniel Ferreira
Published: (2018-11-01)

Beta-blocker therapy after myocardial infarction or acute coronary syndrome: What we don’t know
by: José Ilídio Moreira
Published: (2021-04-01)

Beta-blocker therapy after myocardial infarction or acute coronary syndrome: What we don’t know
by: José Ilídio Moreira
Published: (2021-04-01)

Benefit of ivabradine combined with beta-blocker in comparison with increased dose of beta-blocker in stable angina
by: T. De, et al.
Published: (2014-11-01)

What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndrome? A propensity-score matching analysis
by: Ana Teresa Timóteo, et al.
Published: (2018-11-01)

What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndrome? A propensity-score matching analysis
by: Ana Teresa Timóteo, et al.
Published: (2018-11-01)

Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
by: Pil Hyung Lee, et al.
Published: (2020-12-01)

Impact of frailty on hospital adverse outcomes in elderly admitted with acute coronary syndrome
by: Fernando Montenegro Sá, et al.
Published: (2020-01-01)

LONG SURVIVAL OF PATIENT WITH ROMANO WARD SYNDROME ON BETA BLOCKERS
by: Komal Owais
Published: (2016-02-01)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
by: D V Fettser, et al.
Published: (2009-03-01)

Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients
by: Reunanen Antti, et al.
Published: (2008-06-01)

Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome
by: A. Yu. Proshlyakov, et al.
Published: (2021-07-01)

Efficacy of beta-blocker therapy in symptomatic athletes with exercise-induced intra-ventricular gradients
by: Cotrim Carlos, et al.
Published: (2010-09-01)

The discovery of beta-blockers
by: Subir Kumar Maulik
Published: (2018-01-01)

A study of the use of β-blocker in acute stage of acute coronary syndromes in the prevention of left ventricular remodeling
by: Sow-Fei Lai, et al.
Published: (2004)

Sexual Dysfunction and the Impact of Beta-Blockers in Young Males With Coronary Artery Disease
by: Yuxiang Dai, et al.
Published: (2021-07-01)

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
by: Ph Gabriel Steg, et al.
Published: (2012-01-01)

Clinical Utility of Beta-Blockers for Primary and Secondary Prevention of Coronary Artery Disease
by: Calhoun, McKenzie L., et al.
Published: (2013)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
by: Roberto F.E. Pedretti
Published: (2018-06-01)

Beta-blocker under-use in COPD patients
by: Lim KP, et al.
Published: (2017-10-01)

Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
by: Yan Chen, et al.
Published: (2020-01-01)

Perioperative beta-blocker and its effect on coronary artery bypass graft patients outcome after surgery
by: Mohamed N. Elshafei, et al.
Published: (2020-08-01)

Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma
by: N Y Grigorieva, et al.
Published: (2019-09-01)

Effectiveness of preJhospital betaJblocker therapy in patients with acute coronary syndrome
by: G. M. Baitova, et al.
Published: (2008-02-01)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
by: Valentina Carubelli, et al.
Published: (2021-06-01)

The effect of beta-blockers in acute heart failure according to heart rate
by: Hyun-Jin Kim, et al.
Published: (2021-07-01)

Beta adrenergic blockers poisoning
by: Tadić Milorad, et al.
Published: (2016-01-01)

Residual platelet activity in patients managed with clopidogrel: Clinical implications for the management of patients with acute coronary syndrome
by: João Morais
Published: (2012-09-01)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Ali Mohammed Kareem Al-Jabari, et al.
Published: (2017-09-01)

Ventricular Fibrillation in Patient with Multi-vessel Coronary Spasm Four Days after the Initiation of Oral Beta-blocker
by: Manabu Kurabayashi, et al.
Published: (2016-07-01)